Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer Meeting Abstract
| Authors: | Modi, S.; Saura, C.; Henderson, C. A.; Lin, N. U.; Mahtani, R. L.; Goddard, J.; Rodenas, E.; O'Shaughnessy, J.; Baselga, J. |
| Abstract Title: | Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880300093 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2011.29.15_suppl.590 |
| Notes: | Meeting Abstract: 590 -- Source: Wos |
